VanEck Biotech ETF Rating $179.06 +1.29 (+0.73%) (As of 07/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy2.62Holdings in BBH have an aggregate rating of Moderate Buy based on 435 analyst ratings issued in the past year covering 25 companies (99.9% of the portfolio).BBH Aggregate Price Target$197.4610.27% UpsideHigh Prediction$252.76Average Prediction$197.46Low Prediction$141.90Holdings in BBH have an aggregate price target of $197.46 and a range of $141.90 to $252.76 covering 25 companies (99.9% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.70%AMGNAmgen$334.85+0.2%4.4956 of 5 stars4.50 / 5 stars2.52$312.63 -6.6%21Short Interest ↑Analyst Revision9.97%VRTXVertex Pharmaceuticals$495.26+0.6%3.9637 of 5 stars3.96 / 5 stars2.54$460.30 -7.1%26Upcoming EarningsAnalyst ForecastInsider SellingNews Coverage8.07%REGNRegeneron Pharmaceuticals$1,078.63+1.4%4.2399 of 5 stars4.24 / 5 stars2.78$1,074.95 -0.3%23Upcoming EarningsAnalyst ForecastAnalyst Revision7.46%GILDGilead Sciences$77.01+0.7%4.793 of 5 stars4.79 / 5 stars2.33$81.81 6.2%18Options VolumeAnalyst Revision5.26%ARGXargenx$494.46+1.7%1.0751 of 5 stars1.08 / 5 stars2.90$539.05 9.0%21Earnings ReportAnalyst UpgradeShort Interest ↑News CoverageHigh Trading Volume4.95%IQVIQVIA$239.67+3.2%4.6589 of 5 stars4.66 / 5 stars2.76$263.56 10.0%17Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage4.42%ICLRICON Public$323.46+3.3%4.0046 of 5 stars4.00 / 5 stars3.00$351.33 8.6%10Earnings ReportAnalyst ForecastShort Interest ↓News Coverage4.21%BIIBBiogen$211.17-7.2%4.8342 of 5 stars4.83 / 5 stars2.65$286.00 35.4%26Upcoming EarningsAnalyst ForecastShort Interest ↑Gap Down3.95%MRNAModerna$122.11+1.4%3.2392 of 5 stars3.24 / 5 stars2.28$133.88 9.6%18Upcoming EarningsInsider Selling3.84%ILMNIllumina$120.43+2.7%4.8681 of 5 stars4.87 / 5 stars2.33$158.57 31.7%21Positive News3.22%BGNEBeiGene$162.54-0.4%2.3587 of 5 stars2.36 / 5 stars2.80$250.75 54.3%10Analyst Revision3.11%ALNYAlnylam Pharmaceuticals$234.84-1.3%3.3781 of 5 stars3.38 / 5 stars2.67$256.73 9.3%24Upcoming EarningsShort Interest ↑2.90%NBIXNeurocrine Biosciences$146.80+0.5%4.7048 of 5 stars4.70 / 5 stars2.78$154.08 5.0%23Upcoming EarningsAnalyst ForecastNews Coverage2.58%SRPTSarepta Therapeutics$144.24-2.2%4.9099 of 5 stars4.91 / 5 stars2.78$187.72 30.1%18Short Interest ↓2.47%BMRNBioMarin Pharmaceutical$84.59-1.2%4.8983 of 5 stars4.90 / 5 stars2.55$102.00 20.6%20Analyst ForecastShort Interest ↓Analyst RevisionNews Coverage2.39%TECHBio-Techne$80.60+2.5%4.586 of 5 stars4.59 / 5 stars2.73$81.00 0.5%11Short Interest ↓2.36%NTRANatera$102.67+0.5%1.3314 of 5 stars1.33 / 5 stars3.00$101.19 -1.4%16Upcoming EarningsInsider SellingNews Coverage2.28%CRLCharles River Laboratories International$233.47+5.3%4.5109 of 5 stars4.51 / 5 stars2.50$252.29 8.1%14News CoveragePositive News2.14%INCYIncyte$68.61+0.1%4.6793 of 5 stars4.68 / 5 stars2.39$73.25 6.8%18Upcoming EarningsAnalyst ForecastNews Coverage2.08%BNTXBioNTech$85.94+1.5%2.0441 of 5 stars2.04 / 5 stars2.20$111.70 30.0%10News Coverage1.97%QGENQiagen$43.92+4.0%4.3411 of 5 stars4.34 / 5 stars2.67$51.05 16.2%9Upcoming EarningsPositive News1.57%EXASExact Sciences$45.30-6.3%4.6243 of 5 stars4.62 / 5 stars2.93$85.80 89.4%15Upcoming Earnings1.28%RGENRepligen$140.79+6.4%4.6501 of 5 stars4.65 / 5 stars2.80$194.00 37.8%10Upcoming Earnings0.97%CRSPCRISPR Therapeutics$57.92+0.6%2.054 of 5 stars2.05 / 5 stars2.33$75.71 30.7%18Positive News0.73%CYTKCytokinetics$59.69+2.0%4.2478 of 5 stars4.25 / 5 stars2.83$77.06 29.1%18Insider Selling This page (NASDAQ:BBH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
